Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 3
2002 13
2003 12
2004 25
2005 21
2006 29
2007 27
2008 23
2009 28
2010 23
2011 34
2012 37
2013 25
2014 23
2015 8
2016 13
2017 14
2018 14
2019 6
2020 13
2021 13
2022 13
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

383 results

Results by year

Filters applied: . Clear all
Page 1
Ziprasidone.
Bouchette D, Fariba KA, Patel P, Marwaha R. Bouchette D, et al. 2024 Feb 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2024 Feb 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 28846230 Free Books & Documents.
Ziprasidone, an atypical antipsychotic, is approved by the US Food and Drug Administration (FDA) for the treatment of schizophrenia, bipolar mania, and acute agitation in individuals with schizophrenia. ...The research confirmed the efficacy of ziprasidone in
Ziprasidone, an atypical antipsychotic, is approved by the US Food and Drug Administration (FDA) for the treatment of schizophrenia,
A History of the Pharmacological Treatment of Bipolar Disorder.
López-Muñoz F, Shen WW, D'Ocon P, Romero A, Álamo C. López-Muñoz F, et al. Int J Mol Sci. 2018 Jul 23;19(7):2143. doi: 10.3390/ijms19072143. Int J Mol Sci. 2018. PMID: 30041458 Free PMC article. Review.
In this paper, the authors review the history of the pharmacological treatment of bipolar disorder, from the first nonspecific sedative agents introduced in the 19th and early 20th century, such as solanaceae alkaloids, bromides and barbiturates, to John Cade's experiments …
In this paper, the authors review the history of the pharmacological treatment of bipolar disorder, from the first nonspecific sedati …
Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis.
Bahji A, Ermacora D, Stephenson C, Hawken ER, Vazquez G. Bahji A, et al. J Affect Disord. 2020 May 15;269:154-184. doi: 10.1016/j.jad.2020.03.030. Epub 2020 Mar 20. J Affect Disord. 2020. PMID: 32339131 Review.
OBJECTIVE: We investigated the comparative efficacy and tolerability of pharmacological treatment strategies for the treatment of acute bipolar depression. DATA SOURCES: A systematic review and network meta-analysis was conducted by searching eight registries for published …
OBJECTIVE: We investigated the comparative efficacy and tolerability of pharmacological treatment strategies for the treatment of acute b
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Nomura I, Hatano M, Iwata N. Kishi T, et al. Mol Psychiatry. 2022 Feb;27(2):1136-1144. doi: 10.1038/s41380-021-01334-4. Epub 2021 Oct 12. Mol Psychiatry. 2022. PMID: 34642461 Free PMC article.
A systematic review and random-effects model network meta-analysis was conducted to compare the efficacy, acceptability, tolerability, and safety of pharmacological interventions for adults with acute bipolar mania. We searched PubMed, the Cochrane Library, and Embase data …
A systematic review and random-effects model network meta-analysis was conducted to compare the efficacy, acceptability, tolerability, and s …
Ziprasidone.
[No authors listed] [No authors listed] 2023 Jun 10. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2023 Jun 10. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643974 Free Books & Documents. Review.
Ziprasidone is an atypical antipsychotic used in the treatment of adults with schizophrenia and bipolar disorder. Use of ziprasidone has not been consistently associated with serum enzyme elevations but has been linked to rare instances of hypersensitivity re
Ziprasidone is an atypical antipsychotic used in the treatment of adults with schizophrenia and bipolar disorder. Use of zi
Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials.
Greenberg WM, Citrome L. Greenberg WM, et al. CNS Drug Rev. 2007 Summer;13(2):137-77. doi: 10.1111/j.1527-3458.2007.00008.x. CNS Drug Rev. 2007. PMID: 17627670 Free PMC article. Review.
Oral ziprasidone (ziprasidone hydrochloride) is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia, and acute manic or mixed episodes associated with bipolar disorder (with or without psychotic features). ...The rate of …
Oral ziprasidone (ziprasidone hydrochloride) is approved by the U.S. Food and Drug Administration (FDA) for the treatment of s …
Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review.
Sacchetti E, Galluzzo A, Valsecchi P. Sacchetti E, et al. Expert Rev Clin Pharmacol. 2011 Mar;4(2):163-79. doi: 10.1586/ecp.10.139. Expert Rev Clin Pharmacol. 2011. PMID: 22115400 Review.
Initially approved for the treatment of adults with schizophrenia, ziprasidone has more recently received supplementary indications for acute manic and mixed episodes and as maintenance therapy for people affected by bipolar disorder. ...Emerging evidence indicates …
Initially approved for the treatment of adults with schizophrenia, ziprasidone has more recently received supplementary indications f …
Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.
Kadakia A, Dembek C, Heller V, Singh R, Uyei J, Hagi K, Nosaka T, Loebel A. Kadakia A, et al. BMC Psychiatry. 2021 May 11;21(1):249. doi: 10.1186/s12888-021-03220-3. BMC Psychiatry. 2021. PMID: 33975574 Free PMC article.
This Bayesian network meta-analysis (NMA) compared the relative efficacy and tolerability of AAP monotherapy in adults with bipolar depression. METHODS: Efficacy measures included change in Montgomery Asberg Depression Rating Scale (MADRS), Clinical Global Improvement - …
This Bayesian network meta-analysis (NMA) compared the relative efficacy and tolerability of AAP monotherapy in adults with bipolar d …
Ziprasidone in bipolar disorder.
Versiani M. Versiani M. Expert Opin Pharmacother. 2006 Jun;7(9):1221-8. doi: 10.1517/14656566.7.9.1221. Expert Opin Pharmacother. 2006. PMID: 16732708
Ziprasidone is a second-generation antipsychotic currently marketed for the treatment of schizophrenia and bipolar mania. ...Ziprasidone was very well tolerated by patients with bipolar disorder and did not cause increased weight, glucose or lipid leve
Ziprasidone is a second-generation antipsychotic currently marketed for the treatment of schizophrenia and bipolar mania. ...
Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Mishima K, Iwata N. Kishi T, et al. Mol Psychiatry. 2021 Aug;26(8):4146-4157. doi: 10.1038/s41380-020-00946-6. Epub 2020 Nov 11. Mol Psychiatry. 2021. PMID: 33177610 Free PMC article.
We searched Embase, PubMed, and CENTRAL from inception until 22 May 2020 to investigate which antipsychotics and/or mood stabilizers are better for patients with bipolar disorder in the maintenance phase. We performed two categorical network meta-analyses. ...The second in …
We searched Embase, PubMed, and CENTRAL from inception until 22 May 2020 to investigate which antipsychotics and/or mood stabilizers are bet …
383 results